Home Cart 0 Sign in  
X

[ CAS No. 60710-80-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 60710-80-7
Chemical Structure| 60710-80-7
Chemical Structure| 60710-80-7
Structure of 60710-80-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 60710-80-7 ]

Related Doc. of [ 60710-80-7 ]

Alternatived Products of [ 60710-80-7 ]

Product Details of [ 60710-80-7 ]

CAS No. :60710-80-7 MDL No. :MFCD04039781
Formula : C8H8N2 Boiling Point : -
Linear Structure Formula :- InChI Key :IEWMNQUBZPVSSV-UHFFFAOYSA-N
M.W : 132.16 Pubchem ID :7016428
Synonyms :

Calculated chemistry of [ 60710-80-7 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 40.53
TPSA : 49.81 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.72 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.48
Log Po/w (XLOGP3) : 0.54
Log Po/w (WLOGP) : 1.46
Log Po/w (MLOGP) : 1.12
Log Po/w (SILICOS-IT) : 1.54
Consensus Log Po/w : 1.23

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.44
Solubility : 4.76 mg/ml ; 0.036 mol/l
Class : Very soluble
Log S (Ali) : -1.16
Solubility : 9.19 mg/ml ; 0.0696 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.48
Solubility : 0.442 mg/ml ; 0.00334 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.14

Safety of [ 60710-80-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338-P310 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 60710-80-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 60710-80-7 ]
  • Downstream synthetic route of [ 60710-80-7 ]

[ 60710-80-7 ] Synthesis Path-Upstream   1~13

  • 1
  • [ 60710-80-7 ]
  • [ 2458-12-0 ]
Reference: [1] Chemische Berichte, 1894, vol. 27, p. 2165
  • 2
  • [ 60710-80-7 ]
  • [ 82998-57-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1973, p. 2940 - 2948
  • 3
  • [ 60710-80-7 ]
  • [ 3816-66-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 8, p. 1203 - 1208
[2] Chemische Berichte, 1903, vol. 36, p. 4359[3] Chemische Berichte, 1904, vol. 37, p. 1845
[4] Patent: US5932567, 1999, A,
  • 4
  • [ 939-79-7 ]
  • [ 60710-80-7 ]
YieldReaction ConditionsOperation in experiment
97% With hydrogen In palladium-carbon C.14.b.
3-Amino-4-methylbenzonitrile
120 g of 3-nitro-4-methylbenzonitrile were suspended in 1.2 l of EtOH and hydrogenated in the presence of 7 g of Pd/C(10percent) with 50 l of hydrogen at RT.
After removal of the catalyst on Celite, the solvent was stripped off to result in 95 g of pure product (97percent).
1H-NMR (DMSO-d6; δ in ppm): 7.1 (dd, 1H); 6.90 (d, 1H); 6.85 (dd, 1H); 5.35 (s, 2H, NH2); 2.15 (s, 3H)
Reference: [1] Patent: US6455671, 2002, B1,
[2] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 8, p. 1203 - 1208
[3] Chemische Berichte, 1903, vol. 36, p. 4359[4] Chemische Berichte, 1904, vol. 37, p. 1845
[5] Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 1997, vol. 53, # 2, p. 141 - 150
[6] Patent: WO2006/86255, 2006, A2, . Location in patent: Page/Page column 39-40
[7] Patent: US5932567, 1999, A,
[8] Patent: WO2007/88400, 2007, A1, . Location in patent: Page/Page column 13
[9] Patent: WO2009/93049, 2009, A1, . Location in patent: Page/Page column 36-37
[10] RSC Advances, 2015, vol. 5, # 105, p. 86529 - 86535
  • 5
  • [ 39478-78-9 ]
  • [ 60710-80-7 ]
YieldReaction ConditionsOperation in experiment
75% With 2-(2-methoxyphenyl)-1-methyl-3-(diphenylphosphino)-1H-indole; potassium <i>tert</i>-butylate; triethylamine; bis(dibenzylideneacetone)-palladium(0) In dichloromethane; water; acetonitrile at 50℃; for 24 h; Inert atmosphere General procedure: An oven-dried Schlenk tube with the presence of magnetic stir bar which is Teflon-coated was charged with Pd(dba)2 (11.5 mg, 0.02 mmol, 2 molpercent) and ligand L4 (8.4 mg, 0.02 mmol, 2 molpercent). The flask was evacuated and backfilled with nitrogen (3 cycles). Pre-complexation of palladium and ligand was initiated by injecting freshly distilled dry dichloromethane (2.0 mL) and Et3N (0.1 mL) into the tube. The solution was stirred and warmed with hair drier till the solvent condensed on the tube wall. The solvent was removed under vacuum. Aryl bromide (1.0 mmol), KOt-Bu (0.25 mmol), and potassium hexacyanoferrate(II) trihydrate (0.23 mmol) were charged successively to the tube followed by another 3 evacuation-nitrogen refill cycles. Water (1.0 mL) and acetonitrile (1.0 mL) were used as a solvent mixture. The tube was immersed into a preheated 50 °C oil bath for 24 hours. The reaction was quenched by cooling to ambient temperature and added with EtOAc and water. The organic supernatant was analyzed by GC. The organic layer was separated and the remained aqua medium was further extracted with EtOAc (10 mL .x. 3). The combined organic phases were concentrated under reduced pressure. The crude product was purified by flash column chromatography on silica gel (230-400 mesh). The pure fractions were collected, dried under vacuum, and followed by proton (1H) and carbon (13C) NMR characterization
Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 52, p. 7038 - 7041
  • 6
  • [ 19406-86-1 ]
  • [ 60710-80-7 ]
YieldReaction ConditionsOperation in experiment
87% at 315℃; for 1 h; General procedure: Following the amide intermediate Preparation Example A. The reaction vessel is closed (when the amide intermediate has a boiling point at normal pressure equal to or lower than the reaction temperature TB described below) or the reaction vessel is kept open (when the amide intermediate has a boiling point higher than the normal pressure When the reaction temperature is TB), the stirring is continued (600 r/min), the reaction temperature is changed to TB, and after the reaction temperature TB is maintained for TD hours, the reaction is almost complete. Then, the reaction vessel was sealed and connected to a vacuum pump so that the degree of vacuum in the reaction vessel reached 20-50 mbar (according to the type of nitrile product) and the distillate was used as the nitrile product. The yield of the nitrile product was calculated and sampled for nuclear magnetic proteomics and elemental analysis to characterize the nitrile product obtained. Specific reaction conditions and characterization results are shown in Tables A-7, A-8, A-9, A-10 and A-11 below. These characterization results show that the nitrile product obtained has an extremely high purity (above 99percent).In these nitrile product preparation examples, 10 g of diphosphorus pentoxide was optionally added to the reaction vessel as a catalyst at the start of the reaction.
Reference: [1] Patent: CN104557357, 2018, B, . Location in patent: Paragraph 0150; 0151; 0152; 0159
  • 7
  • [ 39478-78-9 ]
  • [ 557-21-1 ]
  • [ 60710-80-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 3, p. 612 - 626
  • 8
  • [ 104-85-8 ]
  • [ 60710-80-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 8, p. 1203 - 1208
  • 9
  • [ 74-90-8 ]
  • [ 95-79-4 ]
  • [ 60710-80-7 ]
Reference: [1] Patent: US2716646, 1951, ,
[2] Patent: DE943225, 1952, ,
  • 10
  • [ 90178-80-6 ]
  • [ 60710-80-7 ]
Reference: [1] Chemische Berichte, 1894, vol. 27, p. 2165
  • 11
  • [ 874-86-2 ]
  • [ 60710-80-7 ]
Reference: [1] Chemische Berichte, 1894, vol. 27, p. 2165
  • 12
  • [ 2458-12-0 ]
  • [ 60710-80-7 ]
Reference: [1] Patent: CN104557357, 2018, B,
  • 13
  • [ 60710-80-7 ]
  • [ 421551-82-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 3, p. 612 - 626
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 60710-80-7 ]

Aryls

Chemical Structure| 1885-29-6

[ 1885-29-6 ]

2-Aminobenzonitrile

Similarity: 0.97

Chemical Structure| 873-74-5

[ 873-74-5 ]

4-Aminobenzonitrile

Similarity: 0.97

Chemical Structure| 50670-64-9

[ 50670-64-9 ]

5-Amino-2-methylbenzonitrile

Similarity: 0.94

Chemical Structure| 72115-06-1

[ 72115-06-1 ]

4-Amino-2-methylbenzonitrile

Similarity: 0.94

Chemical Structure| 90557-28-1

[ 90557-28-1 ]

3-Amino-2,5-dimethylbenzonitrile

Similarity: 0.91

Amines

Chemical Structure| 1885-29-6

[ 1885-29-6 ]

2-Aminobenzonitrile

Similarity: 0.97

Chemical Structure| 873-74-5

[ 873-74-5 ]

4-Aminobenzonitrile

Similarity: 0.97

Chemical Structure| 50670-64-9

[ 50670-64-9 ]

5-Amino-2-methylbenzonitrile

Similarity: 0.94

Chemical Structure| 72115-06-1

[ 72115-06-1 ]

4-Amino-2-methylbenzonitrile

Similarity: 0.94

Chemical Structure| 90557-28-1

[ 90557-28-1 ]

3-Amino-2,5-dimethylbenzonitrile

Similarity: 0.91

Nitriles

Chemical Structure| 1885-29-6

[ 1885-29-6 ]

2-Aminobenzonitrile

Similarity: 0.97

Chemical Structure| 873-74-5

[ 873-74-5 ]

4-Aminobenzonitrile

Similarity: 0.97

Chemical Structure| 50670-64-9

[ 50670-64-9 ]

5-Amino-2-methylbenzonitrile

Similarity: 0.94

Chemical Structure| 72115-06-1

[ 72115-06-1 ]

4-Amino-2-methylbenzonitrile

Similarity: 0.94

Chemical Structure| 90557-28-1

[ 90557-28-1 ]

3-Amino-2,5-dimethylbenzonitrile

Similarity: 0.91